Breast Implants - Market Insights, Competitive Landscape and Market Forecast-2027

Breast Implants - Market Insights, Competitive Landscape and Market Forecast-2027

Breast Implants Market By Product Type (Silicone Breast Implants, Saline Breast Implants), By Shape (Round And Anatomical), By Texture (Smooth And Textured), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), by geography, is anticipated to grow at a significant CAGR forecast till 2027 owing to the growing preferences to enhance physical appearances among the women and rising prevalence of breast cancer, globally

The global breast implants market was valued at USD 1.93 billion in 2021, growing at a CAGR of 7.00% during the forecast period from 2022 to 2027, to reach USD 2.89 billion by 2027. The increase in demand for breast implants is predominantly attributed to the growing incidence of breast cancer among the population across the globe. In addition, the rise in demand for cosmetic surgeries among women to enhance their aesthetic appeal could also be a potential factor for increasing the market for breast implants. Moreover, an increase in the number of breast augmentation surgeries and technological advancement in the product portfolio is expected to bolster the breast implant market during the forecast period.

Breast Implants Market Dynamics:

The market for breast implants is gaining momentum at present owing to the rising burden of breast cancer cases across the globe. This is because women who undergo mastectomy or lumpectomy may have breast reconstruction, either with a saline or silicone implant, tissue from another part of the body, or a combination of the two which is likely to increase the demand for breast implant thereby propelling the market during the forecast period.

For instance, according to the data published by the World Health Organization in the year 2021, there were approximately 2.3 million women diagnosed with breast cancer in the year 2020. Moreover, as per the same source, the 5-year prevalence of breast cancer worldwide by the end of the year 2020 was 7.8 million.

In addition, exponentially increasing old age women, worldwide is also expected to raise the demand for breast implants. This is because more women in their 60s and beyond are seeking breast enhancement surgeries to boost their self-confidence and enhance body image. For instance, according to the United Nations World Population Ageing 2020 Highlights, there were an estimated 727 million persons aged 65 years or above in the world and women accounted for 55 % of the global population is aged 65 years or over.

Furthermore, approval of various technologically advanced products is also expected to contribute to the market growth for breast implants in the upcoming years. For instance, in December 2020, Establishment Labs Holdings Inc., a medical technology company focused on developing products for the breast aesthetics and reconstruction market received a CE mark for its next-generation Motiva Ergonomix2® silicone breast implant platform. The CE mark also includes the Motiva Ergonomix2 Diamond® breast implant, which is the implant that will be used in the Motiva Mia® minimally invasive breast augmentation system when it is approved.

Thus, all the above-mentioned factors are likely to bolster the breast implant in the forthcoming years.

However, the risk associated with breast implants and the stringent regulatory approval process of the product are likely to impede the market growth.

In addition, the unprecedented COVID-19 outbreak has slowed down the global market for breast implants during the initial phases. Nationwide lockdown, canceled or denied elective surgeries to prevent the transmission of the infection, disruptive supply chain due to logistical restriction across the border are some of the reasons that lead to the sluggish market growth of breast implants. According to the World Health Organization “pulse survey” published in the year 2021, about 90% of countries reported one or more disruptions to essential health services. Potentially life-saving emergency, critical, and surgical care interventions are still disrupted in about 20% of countries, reflecting the most immediate indirect consequences of the pandemic. Moreover, two-thirds of countries reported disruptions in elective surgeries, with accumulating consequences as the pandemic is prolonged. Also, as per the statistics published by the American Society of Plastic Surgeons in the year 2021, there was an overall 15% reduction in the total number of cosmetic surgeries which included, nose reshaping, breast augmentation, and others in the year 2020. The data also stated that there was an approximately 33% decrease in breast augmentation procedures during the same year. However, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains including healthcare services, thereby paving the way for a sound period of recovery for the breast implant market.

Breast Implants Market Segment Analysis:

Breast Implants Market By Product Type (Silicone Breast Implants, Saline Breast Implants), By Shape (Round And Anatomical), By Texture (Smooth And Textured), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Breast Implants product type segment, the silicone breast implant is anticipated to hold a significant market during the forecasted period. Silicone implants are particularly good for women who do not have much soft tissue coverage, offering a more natural, softer feel that is closer to natural breast tissue. Moreover, silicone gel implants come from the manufacturer pre-filled whereas saline implants are filled post-implantation. Thus, the advantages associated with a silicone breast implant are likely to boost the segmental growth of the market.

Furthermore, the rising company’s focus on research and developing new silicone-based breast implants could also augment the market for silicone breast implants in the forthcoming years.

For instance, Symatese Aesthetics started a clinical trial to evaluate the safety and performance of the ESTYME® MATRIX Round and Anatomical Silicone Gel-Filled Breast Implants in the breast augmentation and reconstruction in the year 2018. The company completed its trial in April 2021.

Additionally, the company’s expanding the market for silicone-based breast implants would also contribute to the market in the upcoming years. For instance, in November 2019, Sientra acquired the independently operated OPUS® breast implant manufacturing operation (an FDA-approved silicone breast implant manufacturing operation in Franklin) from Lubrizol Life Science.

Hence, the interplay of all the aforementioned factors is projected to drive the segmental growth of the breast implant market in the forthcoming years.

North America is expected to dominate the overall Breast Implants Market:

Among all the regions, North America is expected to occupy a major share in the overall breast implants market during the forecasted period. This domination is owing to the increasing number of breast reconstructive and cosmetic surgeries in the region. Moreover, the growing burden of cancer, the growing burden of old-aged women at present as compared to the previous years, and the presence of key market players in the region are some of the factors responsible for the growth of the breast implants market in the region.

For instance, according to the data published by the American Society of Plastic Surgeons in the year 2020, approximately 193,073 breast augmentation and 1,179 breast implant procedures were performed in the US in the same year.

Additionally, as per the above report, approximately 137,808 breast reconstruction surgeries were performed in the US in the year 2020.

Thus, the growing number of breast cosmetic surgeries and reconstruction procedures is anticipated to upsurge the demand for breast implants in the region thereby propelling the market for the implants during the forthcoming years.

Furthermore, the rising incidence of breast cancer in the region would also contribute to the growth of the regional breast implant market. For instance, according to the GLOBOCAN observatory data, published in the year 2020, there were an estimated 253, 465 breast cancer cases in the US in the year 2020 which accounted for about 11.1% of the total new cancer cases.

Also, according to various studies, more than 100,000 women in the US undergo mastectomies which could increase the demand for breast implants thereby augmenting the market.

Moreover, awareness programs launched by various key market players in the region to highlight the reconstruction options following breast cancer mastectomies could also drive the market for breast implants during the upcoming years. For instance, in October 2021, AbbVie, a manufacturer of breast implants launched a breast cancer campaign to highlight reconstruction options among women.

Hence, the interplay of all the above-mentioned factors is projected to spur the regional breast implants market during the forecasted period.

Breast Implants Market Key Players:

Some of the key market players operating in the Breast Implants market include Johnson & Johnson, HansBioMed., AbbVie Inc., IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, Sientra, Inc., Establishment Labs S.A., Silimed, Wanhe Reserved, CEREPLAS, Laboratories Arion, and others.

Recent Developmental Activities in the Breast Implants Market:

• On May 25, 2021, GC Aesthetics, Inc., a privately-held medical technology company providing aesthetic solutions launched its next generation of breast implants, PERLE™.
• On January 13, 2021, Mentor Worldwide LLC, a part of the Johnson & Johnson Medical Devices Companies received the US Food and Drug Administration (FDA) approved the MENTOR® MemoryGel BOOST™ Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction.

Key Takeaways from the Breast Implants Market Report Study

• Market size analysis for current market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Breast Implants market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the Global Breast Implants Market.
• Various opportunities available for the other competitor in the Breast Implants Market space.
• What are the top-performing segments in 2021? How these segments will perform in 2027.
• Which are the top-performing regions and countries in the current market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Breast Implants market growth in the coming future?

Target Audience who can be benefited from the Breast Implants Market Report Study

• Breast Implants providers
• Research organizations and consulting companies
• Breast Implants-related organization, association, forum, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders in Breast Implants
• Various End-users who want to know more about the Breast Implants Market and the latest technological developments in the Breast Implants market.

Frequently Asked Questions for the Breast Implants Market:

1. What are Breast Implants?

Breast implants are prostheses (artificial devices) that are surgically inserted in the breast to change the shape, size, and contour of a person’s breast. These implants are generally used for restoring a natural breast appearance following a mastectomy, to correct congenital defects and deformities of the chest wall, or, cosmetically, to enhance the look of the breast through breast augmentation surgery.

2. What is the market for Global Breast Implants?

The global breast implants market was valued at USD 1.93 billion in 2021, growing at a CAGR of 7.00% during the forecast period from 2022 to 2027, to reach USD 2.89 billion by 2027.

3. What are the drivers for the Global Breast Implants?

The major factor driving the demand for Breast Implants is the growing incidence of breast cancer among the population across the globe. In addition, the rise in demand for cosmetic surgeries among women to enhance their aesthetic appeal could also be a potential factor for increasing the market for breast implants. Moreover, an increase in the number of breast augmentation surgeries and technological advancement in the product portfolio is expected to bolster the breast implant market during the forecasted period.

4. What are the key players operating in Global Breast Implants?

Some of the key market players operating in the Breast Implants market include Johnson & Johnson, HansBioMed., AbbVie Inc., IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, Sientra, Inc., Establishment Labs S.A., Silimed, Wanhe Reserved, CEREPLAS, Laboratories Arion, and others.

5. Which region has the highest share in the Breast Implants market?

Among all the regions, North America is expected to occupy a major share in the overall breast implants market during the forecasted period. This domination is owing to the increasing number of breast reconstructive and cosmetic surgeries in the region. Moreover, the growing burden of cancer, the growing burden of old-aged women at present as compared to the previous years, and the presence of key market players in the region are some of the factors responsible for the growth of the breast implants market in the region.

Please Note: It will take 7-10 business days to complete the report upon order confirmation.